Compound Radar

Medtronic plc (MDT) Stock Analysis

Price $92.39
Market cap $118.18B
Next earnings Nov 17, 2026
Entry status Watch $84.74–$89.98

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

65
65/100 Good Quality
  • Financial Health 65
  • Profitability 60
  • Business Quality 80
  • Balance Sheet 55
  • Cash Flow 60

Why this rating?

Health 65/100 — Good Quality

Strongest Business Quality 80/100
Softest Balance Sheet 55/100
Watch

Worth tracking, but timing is mixed — not a clear setup yet.

Company overview

Medtronic plc (MDT) is a Medical Devices company in the Healthcare sector. Compound Radar rates Medtronic plc 65/100 (Good Quality) due to high business quality, steady revenue growth, and manageable leverage.

Investment profile

  • Quality High
  • Growth Moderate
  • Balance Sheet Adequate
  • Valuation Attractive

Financial highlights

Valuation

  • P/E 22.76
  • Forward P/E 14.44
  • PEG 1.69
  • EV/Revenue 3.74

Profitability

  • Revenue Growth 13.7%
  • Gross Margin 65.3%
  • Operating Margin 19.3%
  • Net Margin 13.9%
  • ROE 10.6%

Financial strength

  • Cash $8.82B
  • Debt $28.15B
  • Net Cash $-19.33B
  • Free Cash Flow $5.43B
  • Current Ratio 2.07

Similar companies

Peers in Medical Devices, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Devices →

FAQ

How Compound Radar scores and tracks Medtronic plc (MDT).

View Methodology & FAQ →